Autolus Therapeutics plc vs 4D Molecular Therapeutics, Inc., risk disclosures compared

4topics both disclose

6only Autolus Therapeutics plc

0only 4D Molecular Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	Autolus Therapeutics plc	4D Molecular Therapeutics, Inc.
Internal Control	3	6
Ransomware	4	3
Restatement	1	5
Third Party Risk Management	3	3

Only Autolus Therapeutics plc

Topic	Filings
Cross Border Data Transfer	4
ESG Reporting	3
Data Breach	2
Artificial Intelligence	1
Cybersecurity Incident	1
Enforcement Action	1

Only 4D Molecular Therapeutics, Inc.

Nothing.

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

Autolus Therapeutics plc · 4D Molecular Therapeutics, Inc. · All companies